Skip to main content

Table 5 Factors associated with Lower Body Mass Index (BMI)

From: Impact of malnutrition on systemic immune and metabolic profiles in type 2 diabetes

 

OR (95% CI)

p Value

aOR (95% CI)

p Value

Age in Years

0.97 (0.93–1.02)

0.231

  

Gender [Male]

1.00 (0.43–2.31)

> 0.950

  

Urea (mg/dl)

1.98 (0.74–5.30)

0.176

1.83 (0.67–5.00)

0.236

Creatinine (mg/dl)

3.42 (0.57–20.58)

0.18

3.21 (0.51–20.07)

0.213

ALT (U/L)

1.49 (0.74–2.99)

0.262

1.45 (0.71–2.95)

0.311

AST (U/L)

1.14 (0.64–2.03)

0.651

1.12 (0.62–2.01)

0.711

Serum triglycerides (mg/dl)

1.43 (0.80–2.56)

0.227

1.63 (0.87–3.06)

0.125

HDL (ml/dl)

1.70 (0.56–5.15)

0.348

1.78 (0.58–5.50)

0.316

LDL (ml/dl)

1.12 (0.43–2.92)

0.816

1.13 (0.43–2.97)

0.81

RBG (mg/dl)

92.36 (9.17–929.76)

< 0.001

91.26 (9.03–922.12)

< 0.001

HbA1c

14.40 (3.43–60.53)

< 0.001

15.66 (3.61–67.88)

< 0.001

Insulin (pg/ml)

1.94 (1.27–2.94)

0.002

1.93 (1.25–2.97)

0.003

Glucagon (pg/ml)

5.33 (2.00–14.21)

< 0.001

5.17 (1.92–13.89)

0.001

Adiponectin (pg/ml)

1.44 (1.04–1.98)

0.026

1.44 (1.04–1.99)

0.027

Adipsin (pg/ml)

1.44 (1.10–1.90)

0.009

1.52 (1.14–2.05)

0.005

Resistin (pg/ml)

1.28 (0.78–2.10)

0.332

1.33 (0.80–2.21)

0.272

Leptin (pg/ml)

0.60 (0.38–0.96)

0.035

0.59 (0.37–0.95)

0.031

Visfatin (pg/ml)

1.05 (0.69–1.60)

0.821

1.01 (0.66–1.55)

> 0.950

IFN-γ (pg/ml)

0.21 (0.06–0.68)

0.009

0.19 (0.06–0.64)

0.007

IL-2 (pg/ml)

0.37 (0.18–0.77)

0.008

0.35 (0.16–0.75)

0.007

TNF-α (pg/ml)

0.31 (0.12–0.79)

0.015

0.32 (0.13–0.84)

0.02

IL-17A (pg/ml)

0.55 (0.31–0.97)

0.04

0.57 (0.32–1.02)

0.057

IL-17F (pg/ml)

0.59 (0.33–1.06)

0.078

0.58 (0.32–1.05)

0.073

IL-22 (pg/ml)

0.71 (0.43–1.17)

0.177

0.64 (0.38–1.08)

0.095

IL-4 (pg/ml)

0.18 (0.07–0.46)

< 0.001

0.18 (0.07–0.46)

< 0.001

IL-5 (pg/ml)

0.16 (0.05–0.52)

0.003

0.17 (0.05–0.56)

0.004

IL-13 (pg/ml)

0.52 (0.32–0.82)

0.005

0.48 (0.29–0.78)

0.003

IL-10 (pg/ml)

0.06 (0.01–0.46)

0.006

0.05 (0.01–0.39)

0.004

TGF-β (pg/ml)

0.52 (0.32–0.82)

0.005

0.48 (0.29–0.78)

0.003

GM-CSF (pg/ml)

0.55 (0.33–0.92)

0.022

0.55 (0.33–0.93)

0.024

G-CSF (pg/ml)

0.19 (0.06–0.62)

0.006

0.19 (0.06–0.67)

0.009

MCP-1 (pg/ml)

0.41 (0.24–0.71)

0.001

0.41 (0.23–0.71)

0.002

MIP-1β (pg/ml)

0.64 (0.42–0.97)

0.034

0.65 (0.43–0.99)

0.045

IL-6 (pg/ml)

0.25 (0.14–0.48)

< 0.001

0.24 (0.13–0.46)

< 0.001

IL-7 (pg/ml)

0.60 (0.34–1.07)

0.085

0.57 (0.31–1.06)

0.076

IL-8 (pg/ml)

0.29 (0.18–0.49)

< 0.001

0.28 (0.17–0.48)

< 0.001

IL-12 (pg/ml)

0.36 (0.11–1.13)

0.081

0.39 (0.12–1.27)

0.118

IL-1β (pg/ml)

0.51 (0.26–0.99)

0.048

0.50 (0.25–0.99)

0.048

  1. OR Univariate Odds Ratio; aOR Multivariate Odds Ratio adjusted for Age and Gender